DIS
70
2
GRMN
53
3
UPS
51
6
ILMN
31
4
ESS
44
5
PPL
44
9
AON
25
4
TRV
34
4
MSFT
55
2
GD
42
4
SLG
37
6
PFG
27
7
CME
59
3
IR
46
3
NEM
30
2
CAH
44
7
AES
47
4
UNP
38
5
AMT
30
2
RRC
52
2
DIS
70
2
GRMN
53
3
UPS
51
6
ILMN
31
4
ESS
44
5
PPL
44
9
AON
25
4
TRV
34
4
MSFT
55
2
GD
42
4
SLG
37
6
PFG
27
7
CME
59
3
IR
46
3
NEM
30
2
CAH
44
7
AES
47
4
UNP
38
5
AMT
30
2
RRC
52
2
Financhill
Back

Harvard Bioscience 10K Form

Sell
40

HBIO
Harvard Bioscience

Last Price:
$2.11
Seasonality Move:
6.15%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-07 10Q HBIO/Harvard Bioscience Quarterly
2023-11-07 10Q HBIO/Harvard Bioscience Quarterly
2023-08-08 10Q HBIO/Harvard Bioscience Quarterly
2023-04-26 10Q HBIO/Harvard Bioscience Quarterly
2022-11-09 10Q HBIO/Harvard Bioscience Quarterly
2022-08-04 10Q HBIO/Harvard Bioscience Quarterly

Receive HBIO News And Ratings

See the #1 stock for the next 7 days that we like better than HBIO

HBIO Financial Statistics

Sales & Book Value

Annual Sales: $112.3M
Cash Flow: $-2M
Price / Cash Flow: 569.49
Annual Sales: $1.50
Price / Book: 1.41

Profitability

EPS (TTM): -0.33000
Net Income (TTM): $-14.2M
Gross Margin: $66.1M
Return on Equity: -20.42%
Return on Assets: -10.62%

Harvard Bioscience Earnings Forecast

Key Harvard Bioscience Financial Ratios

  • The Gross Profit Margin over the past 26 years for HBIO is 58.86%.
  • The Selling, General & Administrative Expenses for HBIO have been equal to 41.77% of Gross Profit Margin.
  • The Research & Development expenses have been 10.48% of Revenue.
  • The Interest Expense is -105.15% of Operating Income.
  • The Net Earning history of HBIO is -3.04% of Total Revenues.
  • Per Share Earnings over the last 26 years have been positive in 13 years.

Harvard Bioscience Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: HBIO
CUSIP: 416906
Website: harvardbioscience.com

Debt

Debt-to-Equity Ratio: 0.58
Current Ratio: 2.06
Quick Ratio: 0.76

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 16.84

HBIO Technical Analysis vs Fundamental Analysis

Sell
40
Harvard Bioscience (HBIO) is a Sell

Is Harvard Bioscience a Buy or a Sell?